Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: The results of double-blinded placebo-controlled study

Acta Diabetologica

Volumn 45, Issue 1, 2008, Pages 1-6

  Sobenin, Igor A ^a,c   Nedosugova, Lyudmila V ^b   Filatova, Lyudmila V ^c   Balabolkin, Mikhail I ^b   Gorchakova, Tatiana V ^a,c   Orekhov, Alexander N ^a,d  

^a INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^b Russian Medical Academy of Postgraduate Education   (Russian Federation)

^c INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^d Institute of Chemical Problems of Ecology   (Russian Federation)

Author keywords

Diabetes mellitus; Garlic; Hyperglycemia; Metabolic control; Placebo controlled study

Indexed keywords

ALLICOR; ANTIDIABETIC AGENT; CHOLESTEROL; FRUCTOSAMINE; GLUCOSE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GARLIC; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLOW RELEASE FORMULATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; FRUCTOSAMINE; GARLIC; HUMANS; LIPIDS; MALE; MIDDLE AGED; PLACEBOS; POWDERS; TABLETS;

EID: 39049143752     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0011-x     Document Type: Article

References (50)

1. Krolewski AS, Warram JH, Valsania P, Martin BC, Laffel LM, Christlieb AR (1991) Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med 90:56S-61S
2. Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T (1993) Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. An autopsy study from the Honolulu Heart Program. Am J Epidemiol 137:1328-1340
3. Schwartz CJ, Valente AJ, Sprague EA (1993) A modern view of atherogenesis. Am J Cardiol 71:9B-14B
4. Pyorala K, Laakso M, Uusitupa M (1987) Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3:463-524
5. Nesto R (2001) CHD: a major burden in type 2 diabetes. Acta Diabetol 38(1):S3-S8
6. Swanston-Flatt SK, Flatt PR, Day C, Bailey CJ (1991) Traditional dietary adjuncts for the treatment of diabetes mellitus. Proc Nutr Soc 50:641-651
7. Harenberg J, Giese C, Zimmermann R (1988) Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia. Atherosclerosis 74:247-249
8. Berthold HK, Sudhop T (1998) Garlic preparations for prevention of atherosclerosis. Curr Opin Lipidol 9:565-569
9. Wang HX, Ng TB (1999) Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities. Life Sci 65:2663-2677
10. Kruse-Jarres JD, Jarausch J, Lehmann P, Vogt BW, Rietz P (1989) A new colorimetric method for the determination of fructosamine. Lab Med 13:245-253
11. Bordia AK, Joshi HK, Sanadhya YK, Bhu N (1977) Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease. Atherosclerosis 28:155-159
12. Lau B, Lam F, Wang-Chen R (1987) Effect of odor-modified garlic preparation on blood lipids. Nutr Res 7:139-149
13. Phelps S, Harris WS (1993) Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 28:475-477
14. Campbell JH, Efendy JL, Smith NJ, Campbell GR (2001) Molecular basis by which garlic suppresses atherosclerosis. J Nutr 131:1006S-1009S
15. Block E (1985) The chemistry of garlic and onions. Sci Am 252:114-119
16. Orekhov AN, Tertov VV (1997) In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells. Lipids 32:1055-1060
17. Yeh YY, Liu L (2001) Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr 131:989S-993S
18. Ledet T, Rasmussen LM, Heickendorff L, Barfod K, Thogersen VB (1990) The nature of large vessel disease in diabetes mellitus. J Diabet Complications 4:63-65
19. Koskinen SV, Reunanen AR, Martelin TP, Valkonen T (1998) Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus. Am J Public Health 88:765-770
20. Goraya TY, Leibson CL, Palumbo PJ (2002) Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 40:946-953
21. Nesto RW, Rutter MK (2002) Impact of the atherosclerotic process in patients with diabetes. Acta Diabetol 39(2):S22-S28
22. Koskinen P, Irjala K, Viikari J, Panula O, Matikainen MT (1987) Serum fructosamine in the assessment of glycaemic control in diabetes mellitus. Scand J Clin Lab Invest 47:285-292
23. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D (1982) Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 31:283-291
24. Wiklund O, Witztum JL, Carew TE, Pittman RC, Elam RL, Steinberg D (1987) Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits. J Lipid Res 28:1098-1109
25. Witztum JL, Koschinsky T (1989) Metabolic and immunological consequences of glycation of low density lipoproteins. Prog Clin Biol Res 304:219-234
26. Brownlee M, Vlassara H, Cerami A (1985) Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 34:938-941
27. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438
28. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
29. Mathew PT, Augusti KT (1973) Studies on the effect of allicin (diallyl disulphide-oxide) on alloxan diabetes. I. Hypoglycaemic action and enhancement of serum insulin effect and glycogen synthesis. Indian J Biochem Biophys 10:209-212
30. Jain RC, Vyas CR, Mahatma OP (1973) Hypoglycaemic action of onion and garlic. Lancet 2:1491
31. Jain RC, Vyas CR (1974) Hypoglycaemia action of onion on rabbits. Br Med J 2:730
32. Jain RC, Vyas CR (1975) Garlic in alloxan-induced diabetic rabbits. Am J Clin Nutr 28:684-685
33. Augusti KT, Mathew PT (1975) Effect of allicin on certain enzymes of liver after a short term feeding to normal rats. Experientia 31:148-149
34. Begum H, Bari MA (1985) Effect of garlic oil on the pancreas of experimental diabetes in guineapigs. Bangladesh Med Res Counc Bull 11:64-68
35. Sheela CG, Augusti KT (1992) Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian J Exp Biol 30:523-526
36. Sheela CG, Kumud K, Augusti KT (1995) Anti-diabetic effects of onion and garlic sulfoxide amino acids in rats. Planta Med 61:356-357
37. Augusti KT, Sheela CG (1996) Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue, in diabetic rats. Experientia 52:115-120
38. Farva D, Goji IA, Joseph PK, Augusti KT (1986) Effects of garlic oil on streptozotocin-diabetic rats maintained on normal and high fat diets. Indian J Biochem Biophys 23:24-27
39. Swanston-Flatt SK, Day C, Bailey CJ, Flatt PR (1990) Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia 33:462-464
40. Ohaeri OC (2001) Effect of garlic oil on the levels of various enzymes in the serum and tissue of streptozotocin diabetic rats. Biosci Rep 21:19-24
41. Patumraj S, Tewit S, Amatyakul S (2000) Comparative effects of garlic and aspirin on diabetic cardiovascular complications. Drug Deliv 7:91-96
42. Sitprija S, Plengvidhya C, Kangkaya V, Bhuvapanich S, Tunkayoon M (1987) Garlic and diabetes mellitus phase II clinical trial. J Med Assoc Thai 70(2):223-227
43. Melchinskaya EN, Popovtseva ON, Gromnatskii NI (1997) Immunologic aspects of alisate in diabetes mellitus patients. Biull Eksp Biol Med 124:595-597
44. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105(3):310-315
45. Ide N, Lau BH (1999) Aged garlic extract attenuates intracellular oxidative stress. Phytomedicine 6:125-131
46. Sobenin IA, Maksumova MA, Slavina ES, Balabolkin MI, Orekhov AN (1994) Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages. Atherosclerosis 105:159-163
47. Iberl B, Winkler G, Miller B, Knobloch K (1990) Quantitative determination of allicin and alliin from garlic by HPLC. Planta Med 56:320-326
48. Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y (2001) Intake of garlic and its bioactive components. J Nutr 131:955S-962S
49. Orekhov AN, Tertov VV, Sobenin IA, Pivovarova EM (1995) Direct anti-atherosclerosis-related efects of garlic. Ann Med 27:63-65
50. Orekhov AN, Grunwald J (1997) Effects of garlic on atherosclerosis. Nutrition 13:656-663